NAS:EDSA (Canada) Also Trade In: Canada Germany

Edesa Biotech Inc $ 4.93 -0.28 (-5.42%)

Volume:
105,808
Avg Vol (1m):
143,740
Market Cap $:
47.37 Mil
Enterprise Value $:
44.40 Mil
P/E (TTM):
0.00
P/B:
8.18
Warning! GuruFocus has detected 3 Severe warning signs with EDSA. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for EDSA (Edesa Biotech Inc) from 2010 to Dec 02 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Edesa Biotech stock (EDSA) PE ratio as of Dec 02 2020 is 0. More Details

Edesa Biotech PE Ratio (TTM) Chart

EMBED

Edesa Biotech PE Ratio (TTM) Historical Data

Total 1288
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Edesa Biotech PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2020-12-020.0 2020-09-300.0
2020-12-010.0 2020-09-290.0
2020-11-300.0 2020-09-280.0
2020-11-270.0 2020-09-250.0
2020-11-260.0 2020-09-240.0
2020-11-250.0 2020-09-230.0
2020-11-240.0 2020-09-220.0
2020-11-230.0 2020-09-210.0
2020-11-200.0 2020-09-180.0
2020-11-190.0 2020-09-170.0
2020-11-180.0 2020-09-160.0
2020-11-170.0 2020-09-150.0
2020-11-160.0 2020-09-140.0
2020-11-130.0 2020-09-110.0
2020-11-120.0 2020-09-100.0
2020-11-110.0 2020-09-090.0
2020-11-100.0 2020-09-080.0
2020-11-090.0 2020-09-070.0
2020-11-060.0 2020-09-040.0
2020-11-050.0 2020-09-030.0
2020-11-040.0 2020-09-020.0
2020-11-030.0 2020-09-010.0
2020-11-020.0 2020-08-310.0
2020-10-300.0 2020-08-280.0
2020-10-290.0 2020-08-270.0
2020-10-280.0 2020-08-260.0
2020-10-270.0 2020-08-250.0
2020-10-260.0 2020-08-240.0
2020-10-230.0 2020-08-210.0
2020-10-220.0 2020-08-200.0
2020-10-210.0 2020-08-190.0
2020-10-200.0 2020-08-180.0
2020-10-190.0 2020-08-170.0
2020-10-160.0 2020-08-140.0
2020-10-150.0 2020-08-130.0
2020-10-140.0 2020-08-120.0
2020-10-130.0 2020-08-110.0
2020-10-120.0 2020-08-100.0
2020-10-090.0 2020-08-070.0
2020-10-080.0 2020-08-060.0
2020-10-070.0 2020-08-050.0
2020-10-060.0 2020-08-040.0
2020-10-050.0 2020-08-030.0
2020-10-020.0 2020-07-310.0
2020-10-010.0 2020-07-300.0

Edesa Biotech PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Industry Healthcare » Biotechnology » NAICS : 325412 NAICS : 3741
Traded in other countries KLH.Canada RBTN.Germany EDSA.USA
Address 100 Spy Court, Markham, ON, CAN, L3R 5H6
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side-effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.